BeStock  
Stocks › Biotechnology › CTMX

CytomX CTMX

US equityMarket cap rank #3673Biotechnology
$2.55 −$0.01 (-0.39%)
Pre-market · Oct 8, 8:20 am ET · After hours $2.54 -0.39%
Open$2.53
Prev close$2.56
Day range$2.52 – $2.65
Volume2.34M
Market cap$555.64M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-4.5x
CheapRich

Below its usual level · 25th percentile, 5-year average -8.0x

Price / book1.8x
CheapRich

Around its usual level · 50th percentile, 5-year average -2.3x

#2780 of 5317 stocks by PB (1 = cheapest)

Price / sales30.4x
CheapRich

Near the top of its 5-year range · 97th percentile, 5-year average 4.7x

#4764 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-443x-271x-98x74xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$1.87
Price vs. fair value+36.3%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyExtreme
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.84 – -2.28 50% (cheaper than usual) #2780 of 5317 (1 = cheapest)
PE -4.47 -5.68 -8.04 25% (cheaper than usual) –
PS 30.36 21.01 4.72 97% (pricier than usual) #4764 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$1.87
Economic moatNone
UncertaintyExtreme

Discussion

No comments yet — be the first to weigh in on CTMX.

Leave a comment

Scroll to Top